Pharvaris (PHVS) Net Cash Flow (2020 - 2026)
Pharvaris (PHVS) posted Net Cash Flow of -$57.2 million for Q1 2026, down 30.46% on a QoQ basis from -$43.9 million in Q4 2025, and down 40.55% year-over-year from -$96.3 million in Q1 2025.
Pharvaris (PHVS) Net Cash Flow (2020 - 2026) Analysis & Trends
Pharvaris' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$57.2 million for Q1 2026.
- Quarterly Net Cash Flow fell 40.55% year-over-year to -$57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 111.65% YoY) and the FY2025 annual result came in at $26.4 million, up 120.67% from the prior year.
- Net Cash Flow was -$57.2 million for Q1 2026 at Pharvaris, down from -$43.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $19647.1 billion in Q2 2023 and bottomed at -$19641.1 billion in Q3 2023.
- A 5-year average of $356.6 million and a median of -$27.1 million in 2023 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 385414451.59% in 2023, while the deepest fall reached 127777546.09% in 2023.
- Pharvaris' Net Cash Flow stood at -$21.0 million in 2022, then jumped by 1318.07% to $256.0 million in 2023, then sank by 114.42% to -$36.9 million in 2024, then fell by 18.81% to -$43.9 million in 2025, then sank by 30.46% to -$57.2 million in 2026.
- Business Quant data shows PHVS's Net Cash Flow at -$57.2 million in Q1 2026, -$43.9 million in Q4 2025, and $151.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | -57.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.23 Mn |
| Mar 31, 2026 | -57.23 Mn |
| Dec 31, 2025 | -43.86 Mn |
| Dec 31, 2025 | -43.86 Mn |
| Sep 30, 2025 | 151.68 Mn |
| Sep 30, 2025 | 151.68 Mn |
| Jun 30, 2025 | -33.94 Mn |
| Jun 30, 2025 | -33.94 Mn |
| Mar 31, 2025 | -40.72 Mn |
| Mar 31, 2025 | -40.72 Mn |
| Dec 31, 2024 | -36.92 Mn |
| Dec 31, 2024 | -36.92 Mn |
| Sep 30, 2024 | -35.78 Mn |
| Sep 30, 2024 | -35.78 Mn |
| Jun 30, 2024 | -29.51 Mn |
| Jun 30, 2024 | -29.51 Mn |
| Mar 31, 2024 | -25.49 Mn |
| Mar 31, 2024 | -25.49 Mn |
| Dec 31, 2023 | 255.96 Mn |
| Dec 31, 2023 | 255.96 Mn |